{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:27:08Z","timestamp":1793914028248,"version":"4.8.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s12264-026-01669-4","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T06:28:34Z","timestamp":1783319314000},"page":"2471-2490","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimized Midbrain Organoid Transplantation Restores Dopaminergic Nigrostriatal Pathway and Motor Function in Parkinson\u2019s Disease Mouse Model"],"prefix":"10.1007","volume":"42","author":[{"given":"Lin-Bo","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yu","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Qing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4916-3412","authenticated-orcid":false,"given":"Jun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"1669_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM. Epidemiology of Parkinson\u2019s disease. Lancet Neurol 2006, 5: 525\u2013535.","journal-title":"Lancet Neurol"},{"key":"1669_CR2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet 2021, 397: 2284\u20132303.","journal-title":"Lancet"},{"key":"1669_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrn2477","volume":"9","author":"P Brundin","year":"2008","unstructured":"Brundin P, Li JY, Holton JL, Lindvall O, Revesz T. Research in motion: The Enigma of Parkinson\u2019s disease pathology spread. Nat Rev Neurosci 2008, 9: 741\u2013745.","journal-title":"Nat Rev Neurosci"},{"key":"1669_CR4","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J. Parkinson disease. Nat Rev Dis Primers 2017, 3: 17013.","journal-title":"Parkinson disease. Nat Rev Dis Primers"},{"key":"1669_CR5","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A. Epidemiology of Parkinson\u2019s disease. J Neural Transm 2017, 124: 901\u2013905.","journal-title":"J Neural Transm"},{"key":"1669_CR6","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1212\/WNL.39.7.888","volume":"39","author":"JI Sage","year":"1989","unstructured":"Sage JI, McHale DM, Sonsalla P, Vitagliano D, Heikkila RE. Continuous levodopa infusions to treat complex dystonia in Parkinson\u2019s disease. Neurology 1989, 39: 888.","journal-title":"Neurology"},{"key":"1669_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nm.2165","volume":"16","author":"JA Obeso","year":"2010","unstructured":"Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, et al. Missing pieces in the Parkinson\u2019s disease puzzle. Nat Med 2010, 16: 653\u2013661.","journal-title":"Nat Med"},{"key":"1669_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neuron.2015.03.002","volume":"86","author":"JA Steinbeck","year":"2015","unstructured":"Steinbeck JA, Studer L. Moving stem cells to the clinic: Potential and limitations for brain repair. Neuron 2015, 86: 187\u2013206.","journal-title":"Neuron"},{"key":"1669_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1172\/JCI40543","volume":"120","author":"O Lindvall","year":"2010","unstructured":"Lindvall O, Kokaia Z. Stem cells in human neurodegenerative disorders\u2014time for clinical translation? J Clin Invest 2010, 120: 29\u201340.","journal-title":"J Clin Invest"},{"key":"1669_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ana.21778","volume":"66","author":"CW Olanow","year":"2009","unstructured":"Olanow CW, Kordower JH, Lang AE, Obeso JA. Dopaminergic transplantation for Parkinson\u2019s disease: Current status and future prospects. Ann Neurol 2009, 66: 591\u2013596.","journal-title":"Ann Neurol"},{"key":"1669_CR11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.tips.2009.03.001","volume":"30","author":"O Lindvall","year":"2009","unstructured":"Lindvall O, Kokaia Z. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson\u2019s disease. Trends Pharmacol Sci 2009, 30: 260\u2013267.","journal-title":"Trends Pharmacol Sci"},{"key":"1669_CR12","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.bbadis.2008.10.007","volume":"1792","author":"R Wijeyekoon","year":"2009","unstructured":"Wijeyekoon R, Barker RA. Cell replacement therapy for Parkinson\u2019s disease. Biochim Biophys Acta BBA Mol Basis Dis 2009, 1792: 688\u2013702.","journal-title":"Biochim Biophys Acta BBA Mol Basis Dis"},{"key":"1669_CR13","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","volume":"382","author":"JS Schweitzer","year":"2020","unstructured":"Schweitzer JS, Song B, Herrington TM, Park TY, Lee N, Ko S, et al. Personalized iPSC-derived dopamine progenitor cells for Parkinson\u2019s disease. N Engl J Med 2020, 382: 1926\u20131932.","journal-title":"N Engl J Med"},{"key":"1669_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.stem.2021.01.004","volume":"28","author":"J Piao","year":"2021","unstructured":"Piao J, Zabierowski S, Dubose BN, Hill EJ, Navare M, Claros N, et al. Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01. Cell Stem Cell 2021, 28: 217-229.e7.","journal-title":"Cell Stem Cell"},{"key":"1669_CR15","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.7150\/thno.26643","volume":"8","author":"Y Yuan","year":"2018","unstructured":"Yuan Y, Tang X, Bai YF, Wang S, An J, Wu Y, et al. Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson\u2019s disease model. Theranostics 2018, 8: 4679\u20134694.","journal-title":"Theranostics"},{"key":"1669_CR16","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41591-021-01257-1","volume":"27","author":"Y Tao","year":"2021","unstructured":"Tao Y, Vermilyea SC, Zammit M, Lu J, Olsen M, Metzger JM, et al. Autologous transplant therapy alleviates motor and depressive behaviors in Parkinsonian monkeys. Nat Med 2021, 27: 632\u2013639.","journal-title":"Nat Med"},{"key":"1669_CR17","doi-asserted-by":"publisher","first-page":"15921","DOI":"10.1073\/pnas.1010209107","volume":"107","author":"G Hargus","year":"2010","unstructured":"Hargus G, Cooper O, Deleidi M, Levy A, Lee K, Marlow E, et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A 2010, 107: 15921\u201315926.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1669_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/jnr.24123","volume":"96","author":"AX Sun","year":"2018","unstructured":"Sun AX, Tan EK. Towards better cellular replacement therapies in Parkinson disease. J Neuro Res 2018, 96: 219\u2013221. https:\/\/doi.org\/10.1002\/jnr.24123.","journal-title":"J Neuro Res"},{"key":"1669_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41418-020-0566-4","volume":"28","author":"J Sidhaye","year":"2021","unstructured":"Sidhaye J, Knoblich JA. Brain organoids: An ensemble of bioassays to investigate human neurodevelopment and disease. Cell Death Differ 2021, 28: 52\u201367.","journal-title":"Cell Death Differ"},{"key":"1669_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1056\/NEJMra1806175","volume":"380","author":"M Li","year":"2019","unstructured":"Li M, Izpisua Belmonte JC. Organoids\u2014Preclinical models of human disease. N Engl J Med 2019, 380: 569\u2013579.","journal-title":"N Engl J Med"},{"key":"1669_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41593-021-00802-y","volume":"24","author":"A Gordon","year":"2021","unstructured":"Gordon A, Yoon SJ, Tran SS, Makinson CD, Park JY, Andersen J, et al. Long-term maturation of human cortical organoids matches key early postnatal transitions. Nat Neurosci 2021, 24: 331\u2013342.","journal-title":"Nat Neurosci"},{"key":"1669_CR22","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.cell.2016.04.032","volume":"165","author":"X Qian","year":"2016","unstructured":"Qian X, Nguyen HN, Song MM, Hadiono C, Ogden SC, Hammack C, et al. Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure. Cell 2016, 165: 1238\u20131254.","journal-title":"Cell"},{"key":"1669_CR23","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.stemcr.2014.03.011","volume":"2","author":"J Assawachananont","year":"2014","unstructured":"Assawachananont J, Mandai M, Okamoto S, Yamada C, Eiraku M, Yonemura S, et al. Transplantation of embryonic and induced pluripotent stem cell-derived 3D retinal sheets into retinal degenerative mice. Stem Cell Rep 2014, 2: 662\u2013674.","journal-title":"Stem Cell Rep"},{"key":"1669_CR24","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.stem.2016.07.016","volume":"19","author":"Z Li","year":"2016","unstructured":"Li Z, Araoka T, Wu J, Liao HK, Li M, Lazo M, et al. 3D culture supports long-term expansion of mouse and human nephrogenic progenitors. Cell Stem Cell 2016, 19: 516\u2013529.","journal-title":"Cell Stem Cell"},{"key":"1669_CR25","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.stem.2015.03.004","volume":"16","author":"T Takebe","year":"2015","unstructured":"Takebe T, Enomura M, Yoshizawa E, Kimura M, Koike H, Ueno Y, et al. Vascularized and complex organ buds from diverse tissues via mesenchymal cell-driven condensation. Cell Stem Cell 2015, 16: 556\u2013565.","journal-title":"Cell Stem Cell"},{"key":"1669_CR26","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s12264-023-01065-2","volume":"39","author":"Y Li","year":"2023","unstructured":"Li Y, Zeng PM, Wu J, Luo ZG. Advances and applications of brain organoids. Neurosci Bull 2023, 39: 1703\u20131716.","journal-title":"Neurosci Bull"},{"key":"1669_CR27","doi-asserted-by":"publisher","first-page":"7302","DOI":"10.1038\/s41467-021-27464-5","volume":"12","author":"A Fiorenzano","year":"2021","unstructured":"Fiorenzano A, Sozzi E, Birtele M, Kajtez J, Giacomoni J, Nilsson F, et al. Single-cell transcriptomics captures features of human midbrain development and dopamine neuron diversity in brain organoids. Nat Commun 2021, 12: 7302.","journal-title":"Nat Commun"},{"key":"1669_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0292926","volume":"18","author":"I Pavlinov","year":"2023","unstructured":"Pavlinov I, Tambe M, Abbott J, Nguyen HN, Xu M, Pradhan M, et al. In depth characterization of midbrain organoids derived from wild type iPSC lines. PLoS One 2023, 18: e0292926.","journal-title":"PLoS One"},{"key":"1669_CR29","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.stemcr.2017.03.010","volume":"8","author":"AS Monzel","year":"2017","unstructured":"Monzel AS, Smits LM, Hemmer K, Hachi S, Moreno EL, van Wuellen T, et al. Derivation of human midbrain-specific organoids from neuroepithelial stem cells. Stem Cell Rep 2017, 8: 1144\u20131154.","journal-title":"Stem Cell Rep"},{"key":"1669_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24234","volume":"10","author":"CL Fu","year":"2024","unstructured":"Fu CL, Dong BC, Jiang X, Li D, Yao J. A cell therapy approach based on iPSC-derived midbrain organoids for the restoration of motor function in a Parkinson\u2019s disease mouse model. Heliyon 2024, 10: e24234.","journal-title":"Heliyon"},{"key":"1669_CR31","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.7150\/thno.80271","volume":"13","author":"X Zheng","year":"2023","unstructured":"Zheng X, Han D, Liu W, Wang X, Pan N, Wang Y, et al. Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson\u2019s disease. Theranostics 2023, 13: 2673\u20132692.","journal-title":"Theranostics"},{"key":"1669_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF00234031","volume":"212","author":"A Bj\u00f6rklund","year":"1980","unstructured":"Bj\u00f6rklund A, Schmidt RH, Stenevi U. Functional reinnervation of the neostriatum in the adult rat by use of intraparenchymal grafting of dissociated cell suspensions from the substantia nigra. Cell Tissue Res 1980, 212: 39\u201345.","journal-title":"Cell Tissue Res"},{"key":"1669_CR33","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/ana.410380307","volume":"38","author":"TB Freeman","year":"1995","unstructured":"Freeman TB, Olanow CW, Hauser RA, Nauert GM, Smith DA, Borlongan CV, et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson\u2019s disease. Ann Neurol 1995, 38: 379\u2013388.","journal-title":"Ann Neurol"},{"key":"1669_CR34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archneur.1989.00520420033021","volume":"46","author":"O Lindvall","year":"1989","unstructured":"Lindvall O. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson\u2019s disease: A detailed account of methodology and a 6-month follow-up. Arch Neurol 1989, 46: 615.","journal-title":"Arch Neurol"},{"key":"1669_CR35","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/brain\/awh510","volume":"128","author":"I Mendez","year":"2005","unstructured":"Mendez I, Sanchez-Pernaute R, Cooper O, Vi\u00f1uela A, Ferrari D, Bj\u00f6rklund L, et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson\u2019s disease. Brain 2005, 128: 1498\u20131510.","journal-title":"Brain"},{"key":"1669_CR36","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/16060","volume":"2","author":"P Piccini","year":"1999","unstructured":"Piccini P, Brooks DJ, Bj\u00f6rklund A, Gunn RN, Grasby PM, Rimoldi O, et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson\u2019s patient. Nat Neurosci 1999, 2: 1137\u20131140.","journal-title":"Nat Neurosci"},{"key":"1669_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0168-0102(93)90120-F","volume":"16","author":"H Nishino","year":"1993","unstructured":"Nishino H. Intracerebral grafting of catecholamine producing cells and reconstruction of disturbed brain function. Neurosci Res 1993, 16: 157\u2013172.","journal-title":"Neurosci Res"},{"key":"1669_CR38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1017\/S0317167100032959","volume":"24","author":"V Mehta","year":"1997","unstructured":"Mehta V, Spears J, Mendez I. Neural transplantation in Parkinson\u2019s disease. Can J Neurol Sci 1997, 24: 292\u2013301.","journal-title":"Can J Neurol Sci"},{"key":"1669_CR39","first-page":"S159","volume":"11","author":"A Bj\u00f6rklund","year":"2021","unstructured":"Bj\u00f6rklund A, Parmar M. Dopamine cell therapy: From cell replacement to circuitry repair. J Park Dis 2021, 11: S159\u2013S165.","journal-title":"J Park Dis"},{"key":"1669_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0079-6123(00)27014-3","volume":"127","author":"O Lindvall","year":"2000","unstructured":"Lindvall O, Hagell P. Clinical observations after neural transplantation in Parkinson\u2019s disease. Prog Brain Res 2000, 127: 299\u2013320.","journal-title":"Prog Brain Res"},{"key":"1669_CR41","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/jnen\/60.8.741","volume":"60","author":"P Hagell","year":"2001","unstructured":"Hagell P, Brundin P. Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. J Neuropathol Exp Neurol 2001, 60: 741\u2013752.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1669_CR42","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1093\/brain\/awh649","volume":"128","author":"P Piccini","year":"2005","unstructured":"Piccini P, Pavese N, Hagell P, Reimer J, Bj\u00f6rklund A, Oertel WH, et al. Factors affecting the clinical outcome after neural transplantation in Parkinson\u2019s disease. Brain 2005, 128: 2977\u20132986.","journal-title":"Brain"},{"key":"1669_CR43","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1006\/exnr.1994.1026","volume":"125","author":"LE Annett","year":"1994","unstructured":"Annett LE, Martel FL, Rogers DC, Ridley RM, Baker HF, Dunnett SB. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 1994, 125: 228\u2013246.","journal-title":"Exp Neurol"},{"key":"1669_CR44","doi-asserted-by":"crossref","unstructured":"Winkler C, Kirik D, Bj\u00f6rklund A, Dunnett SB. Chapter 11 Transplantation in the rat model of Parkinson\u2019s disease: Ectopic versus homotopic graft placement. Functional Neural Transplantation II. Novel Cell Therapies For CNS Disorders. Amsterdam: Elsevier, 2000: 233\u2013265.","DOI":"10.1016\/S0079-6123(00)27012-X"},{"key":"1669_CR45","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2014.09.017","volume":"15","author":"S Grealish","year":"2014","unstructured":"Grealish S, Diguet E, Kirkeby A, Mattsson B, Heuer A, Bramoulle Y, et al. Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson\u2019s disease. Cell Stem Cell 2014, 15: 653\u2013665.","journal-title":"Cell Stem Cell"},{"key":"1669_CR46","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.stem.2020.08.014","volume":"28","author":"M Xiong","year":"2021","unstructured":"Xiong M, Tao Y, Gao Q, Feng B, Yan W, Zhou Y, et al. Human stem cell-derived neurons repair circuits and restore neural function. Cell Stem Cell 2021, 28: 112-126.e6.","journal-title":"Cell Stem Cell"},{"key":"1669_CR47","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.stem.2022.01.013","volume":"29","author":"N Moriarty","year":"2022","unstructured":"Moriarty N, Gantner CW, Hunt CPJ, Ermine CM, Frausin S, Viventi S, et al. A combined cell and gene therapy approach for homotopic reconstruction of midbrain dopamine pathways using human pluripotent stem cells. Cell Stem Cell 2022, 29: 434-448.e5.","journal-title":"Cell Stem Cell"},{"key":"1669_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1006\/exnr.1999.7110","volume":"159","author":"C Bentlage","year":"1999","unstructured":"Bentlage C, Nikkhah G, Cunningham MG, Bj\u00f6rklund A. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host. Exp Neurol 1999, 159: 177\u2013190.","journal-title":"Exp Neurol"},{"key":"1669_CR49","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.nbd.2009.07.003","volume":"35","author":"A Gaillard","year":"2009","unstructured":"Gaillard A, Decressac M, Frapp\u00e9 I, Fernagut PO, Prestoz L, Besnard S, et al. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants. Neurobiol Dis 2009, 35: 477\u2013488.","journal-title":"Neurobiol Dis"},{"key":"1669_CR50","doi-asserted-by":"publisher","first-page":"7216","DOI":"10.1523\/JNEUROSCI.16-22-07216.1996","volume":"16","author":"I Mendez","year":"1996","unstructured":"Mendez I, Sadi D, Hong M. Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants. J Neurosci 1996, 16: 7216\u20137227.","journal-title":"J Neurosci"},{"key":"1669_CR51","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1523\/JNEUROSCI.21-10-03521.2001","volume":"21","author":"K Mukhida","year":"2001","unstructured":"Mukhida K, Baker KA, Sadi D, Mendez I. Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral, and intrasubthalamic nucleus dopaminergic transplants. J Neurosci 2001, 21: 3521\u20133530.","journal-title":"J Neurosci"},{"key":"1669_CR52","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1523\/JNEUROSCI.14-06-03449.1994","volume":"14","author":"G Nikkhah","year":"1994","unstructured":"Nikkhah G, Bentlage C, Cunningham MG, Bjorklund A. Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. J Neurosci 1994, 14: 3449\u20133461.","journal-title":"J Neurosci"},{"key":"1669_CR53","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1460-9568.2009.06878.x","volume":"30","author":"LH Thompson","year":"2009","unstructured":"Thompson LH, Grealish S, Kirik D, Bj\u00f6rklund A. Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain. Eur J Neurosci 2009, 30: 625\u2013638.","journal-title":"Eur J Neurosci"},{"key":"1669_CR54","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1016\/j.cell.2024.05.030","volume":"187","author":"TW Kim","year":"2024","unstructured":"Kim TW, Koo SY, Riessland M, Chaudhry F, Kolisnyk B, Cho HS, et al. TNF-NF-\u03baB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons. Cell 2024, 187: 3671-3689.e23.","journal-title":"Cell"},{"key":"1669_CR55","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.stem.2016.07.005","volume":"19","author":"J Jo","year":"2016","unstructured":"Jo J, Xiao Y, Sun AX, Cukuroglu E, Tran HD, G\u00f6ke J, et al. Midbrain-like organoids from human pluripotent stem cells contain functional dopaminergic and neuromelanin-producing neurons. Cell Stem Cell 2016, 19: 248\u2013257.","journal-title":"Cell Stem Cell"},{"key":"1669_CR56","doi-asserted-by":"crossref","unstructured":"Smits LM, Reinhardt L, Reinhardt P, Glatza M, Monzel AS, Stanslowsky N, et al. Modeling Parkinson\u2019s disease in midbrain-like organoids. npj Parkinsons Dis 2019, 5: 5.","DOI":"10.1038\/s41531-019-0078-4"},{"key":"1669_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100524","volume":"2","author":"A Zagare","year":"2021","unstructured":"Zagare A, Gobin M, Monzel AS, Schwamborn JC. A robust protocol for the generation of human midbrain organoids. STAR Protoc 2021, 2: 100524.","journal-title":"STAR Protoc"},{"key":"1669_CR58","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1172\/JCI130767","volume":"130","author":"B Song","year":"2019","unstructured":"Song B, Cha Y, Ko S, Jeon J, Lee N, Seo H, et al. Human autologous iPSC\u2013derived dopaminergic progenitors restore motor function in Parkinson\u2019s disease models. J Clin Investig 2019, 130: 904\u2013920.","journal-title":"J Clin Investig"},{"key":"1669_CR59","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3390\/diagnostics15101232","volume":"15","author":"K Diallo","year":"2025","unstructured":"Diallo K, Degbo\u00e9 Y, Baron M, Bellin-Robert A, Boyer JF, Ruyssen-Witrand A, et al. Predicting clinical response to monoclonal TNF inhibitors in rheumatoid arthritis: A transcriptomic approach based on transmembrane TNF reverse signaling and Nrf2 activation. Diagnostics 2025, 15: 1232.","journal-title":"Diagnostics"},{"key":"1669_CR60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature15526","volume":"527","author":"J Mertens","year":"2015","unstructured":"Mertens J, Wang QW, Kim Y, Yu DX, Pham S, Yang B, et al. Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature 2015, 527: 95\u201399.","journal-title":"Nature"},{"key":"1669_CR61","doi-asserted-by":"publisher","first-page":"12747","DOI":"10.1073\/pnas.1534900100","volume":"100","author":"G Castelo-Branco","year":"2003","unstructured":"Castelo-Branco G, Wagner J, Rodriguez FJ, Kele J, Sousa K, Rawal N, et al. Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc Natl Acad Sci U S A 2003, 100: 12747\u201312752.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1669_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003517","volume":"3","author":"ER Andersson","year":"2008","unstructured":"Andersson ER, Prakash N, Cajanek L, Minina E, Bryja V, Bryjova L, et al. Wnt5a regulates ventral midbrain morphogenesis and the development of A9\u2013A10 dopaminergic cells in vivo. PLoS One 2008, 3: e3517.","journal-title":"PLoS One"},{"issue":"60","key":"1669_CR63","doi-asserted-by":"publisher","DOI":"10.3791\/3234","volume":"2012","author":"SL Thiele","year":"2012","unstructured":"Thiele SL, Warre R, Nash JE. Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson\u2019s disease. JoVE 2012, 2012(60): e3234. https:\/\/doi.org\/10.3791\/3234.","journal-title":"JoVE"},{"key":"1669_CR64","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1016\/j.celrep.2019.08.058","volume":"28","author":"AF Adler","year":"2019","unstructured":"Adler AF, Cardoso T, Nolbrant S, Mattsson B, Hoban DB, Jarl U, et al. hESC-derived dopaminergic transplants integrate into basal ganglia circuitry in a preclinical model of Parkinson\u2019s disease. Cell Rep 2019, 28: 3462-3473.e5.","journal-title":"Cell Rep"},{"key":"1669_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2025.102480","volume":"20","author":"N Moriarty","year":"2025","unstructured":"Moriarty N, Fraser TD, Hunt CPJ, Eleftheriou G, Kauhausen JA, Thompson LH, et al. Exercise promotes the functional integration of human stem cell-derived neural grafts in a rodent model of Parkinson\u2019s disease. Stem Cell Rep 2025, 20: 102480.","journal-title":"Stem Cell Rep"},{"key":"1669_CR66","doi-asserted-by":"publisher","first-page":"13097","DOI":"10.1038\/ncomms13097","volume":"7","author":"B Samata","year":"2016","unstructured":"Samata B, Doi D, Nishimura K, Kikuchi T, Watanabe A, Sakamoto Y, et al. Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1. Nat Commun 2016, 7: 13097.","journal-title":"Nat Commun"},{"key":"1669_CR67","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.stemcr.2014.01.013","volume":"2","author":"D Doi","year":"2014","unstructured":"Doi D, Samata B, Katsukawa M, Kikuchi T, Morizane A, Ono Y, et al. Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Rep 2014, 2: 337\u2013350.","journal-title":"Stem Cell Rep"},{"key":"1669_CR68","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","volume":"480","author":"S Kriks","year":"2011","unstructured":"Kriks S, Shim JW, Piao J, Ganat YM, Wakeman DR, Xie Z, et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease. Nature 2011, 480: 547\u2013551.","journal-title":"Nature"},{"key":"1669_CR69","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2410331121","volume":"121","author":"A Fiorenzano","year":"2024","unstructured":"Fiorenzano A, Storm P, Sozzi E, Bruzelius A, Corsi S, Kajtez J, et al. TARGET-seq: Linking single-cell transcriptomics of human dopaminergic neurons with their target specificity. Proc Natl Acad Sci U S A 2024, 121: e2410331121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1669_CR70","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.stemcr.2015.04.011","volume":"4","author":"S Grealish","year":"2015","unstructured":"Grealish S, Heuer A, Cardoso T, Kirkeby A, J\u00f6nsson M, Johansson J, et al. Monosynaptic tracing using modified rabies virus reveals early and extensive circuit integration of human embryonic stem cell-derived neurons. Stem Cell Rep 2015, 4: 975\u2013983.","journal-title":"Stem Cell Rep"},{"key":"1669_CR71","first-page":"511","volume":"10","author":"S Torikoshi","year":"2020","unstructured":"Torikoshi S, Morizane A, Shimogawa T, Samata B, Miyamoto S, Takahashi J. Exercise promotes neurite extensions from grafted dopaminergic neurons in the direction of the dorsolateral striatum in Parkinson\u2019s disease model rats. J Park Dis 2020, 10: 511\u2013521.","journal-title":"J Park Dis"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-026-01669-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-026-01669-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-026-01669-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:03:13Z","timestamp":1793912593000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-026-01669-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":71,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1669"],"URL":"https:\/\/doi.org\/10.1007\/s12264-026-01669-4","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"22 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Ethics"}}]}}